Office of Drug Security, Integrity, and Recalls
The Goals of Office of Drug Security, Integrity, and Recalls include:
- Promoting the quality, integrity, and security of human drugs for U.S. consumers.
- Addressing the increasingly complex global drug supply chain.
- Minimizing consumer exposure to substandard drugs by addressing supply chain integrity and security issues, such as counterfeit, diverted, or intentionally adulterated drugs, drug imports and exports, and drug recalls.
Office of Drug Security, Integrity, and Recalls Accomplishes this through:
- Risk- and science-based policy development, surveillance, and enforcement.
- Division of Import Operations and Recalls
News and Events
June 11, 2013: Johnson City Physician Sentenced to Serve Two Years in Prison for Unapproved Foreign Drugs June 3, 2013: Illinois Man Sentenced to Serve 72 Months in Prison for Conspiring to Distribute Prescription Drugs Over the Internet
- April 26, 2013: Fraudulent Versions of Botox Found in the United States
- February 5, 2013: Health Care Provider Alert: Another Counterfeit Cancer Medicine Found in United States
January 23, 2013: La Jolla Oncologist and Medical Practice Plead Guilty to Dispensing Unapproved Drugs
- December 19, 2012: Letters to Doctors about Risks of Purchasing Unapproved Versions of Botox and Other Medications from Foreign or Unlicensed Suppliers
- December 11, 2012: Johnson City Physician Pleads Guilty To Receiving Unapproved Drugs
Return to Page: About Office of Drug Security, Integrity, and Recalls